blocks. All studies to determine the timing of the sulfate addition step in the biosynthesis indicated that the sulfate is added prior to the formation of intermediates that possess antimicrobial activity.
Streptomyces toyocaensis when grown in complex fermentation medium produces the peptide antibiotic A47934 ( Fig. 1) (3) . A related antibiotic, A41030A ( Fig. 1) , produced by Streptomyces virginiae, differs from A47934 by the absence of a sulfate group on ring G of the antibiotic (4) . Both antibiotics belong to the general class of glycopeptide antibiotics represented by vancomycin (9) and ristocetin (8) . Structurally, these compounds are heptapeptides that contain unusual amino acids such as ,-hydroxy-3-chlorotyrosine, modified p-hydroxyphenylglycine (PHPG) , and 3,4-dihydroxyphenylglycine (DHPG) units.
A reasonable biosynthetic sequehce for this class of antibiotics would have the pathway grouped into three general stages: (i) synthesis of the unusual amino acids of the peptide core, (ii) assembly of the amino acids into a heptapeptide, and, finally, (iii) modification of the heptapeptide by chlorination, phenol-phenol coupling, and sulfate or sugar addition. Incorporation of 13C-enriched precursors into vancomycin (9) , ristocetin (8) , and ardacin (originally called aridicin [6] ) has provided some information on the synthesis of the unusual amino acids. Tyrosine is incorporated into the 3-hydroxytyrosine units of these antibiotics and is also metabolized to PHPG units. Acetate serves as the precursor for DHPG units. Studies on ardacin (5) suggest that the glycosylations occur subsequent to phenol-phenol coupling of the peptide core.
In this report, we describe studies aimed at understanding the biochemistry and genetics of antibiotic synthesis by S. toyocaensis. prepared by inoculating 0.5 ml of liquid nitrogen stock into 10 ml of vegetative medium. After 2 days at 30°C and 250 rpm, 1 ml of the vegetative culture was inoculated into 10 ml of production medium. Synthesis of A47934 in this medium was complete after 5 days of incubation at 30°C and 250 rpm. The vegetative and production media were described previously (3).
MATERIALS AND METHODS
Bacillus subtilis ATCC 6633 was obtained from the Lilly Culture Collection. When used for the assay of antibiotic A47934, the culture was grown in a minimal agar medium consisting of NaCl, 8.3 g; MgSO4 7H20, 0.14 g; trace element solution, 1.4 ml; K2HPO4, 1 Transport studies were carried out by using S. toyocaensis grown in 10 ml of tryptic soy broth (Difco) for 2 days at 30°C and 250 rpm. Cells were collected by centrifugation, washed twice with defined growth medium, and suspended in the same medium. Defined growth medium contained 3-(Nmorpholino)-2-hydroxypropanesulfonic acid (MOPSO), 10.5 g; galactose, 50 g; L-asparagine, 2 g; L-histidine, 0.25 g; L-cysteine, 0.5 g; NH4NO3, 1 g; K2HPO4, 1 g; NaCl, 0.5 g; MgCl2. 5H20, 0.6 g; Na2SO4, 0.5 g; CoCl2 6H20, 0.002 g; trace metal solution, 2 ml; and deionized water, 1 liter (final pH, 7.0). The trace metal solution consisted of 100 mg each of FeCl2 H20, MnCl2 4H20, ZnCl2, and CaCl2 2H20 in 100 ml of deionized water.
Extraction of A47934. Antibiotic A47934, like many glycopeptide antibiotics, is cell associated and must be extracted from the mycelium. Fermentations (10 ml) of the culture were extracted with 2 ml of 1 M CAPS (3-[cyclohexylamino]-1-propanesulfonic acid; Sigma) buffer at pH 11.0. This treatment raised the pH of the suspension to 10.5. The mycelial mass was removed by centrifugation, and the supernatant was decanted. To this broth was added 2 ml of 1 M phosphate buffer at pH 6.0 for every 10 ml of broth. This routinely returned the pH to 7.0.
Mutants blocked in antibiotic synthesis. S. toyocaensis was mutated as described by Baltz (1) . After segregation, cultures were homogenized, sonicated, and plated on Bennett agar. The resulting clones were transferred to microtiter plates containing the same agar. After 10 days of growth at 30°C, a copy of each plate was made and the original plates were overlaid with B. subtilis. Colonies that did not inhibit the growth of the test strain were picked from the copy plates and streaked out on agar slants. Plugs from the mature slant cultures were retested against B. subtilis, and cultures that were still negative for antibiotic synthesis were regrown in liquid production medium. Isolates that did not produce antibiotic, as determined by lack of activity against B. subtilis and absence of an A47934 peak on high-pressure liquid chromatography (HPLC) (see below), were tested for ability to grow on MSA medium. Those cultures that grew on this medium were designated as prototrophic blocked mutants.
Sulfate-transport-negative mutants. Vegetative mycelial fragments of S. toyocaensis were plated out on minimal medium agar plates containing 0.5 to 2.0% potassium chromate or sodium selenate. Colonies that grew were streaked out onto Bennett agar and then retested on minimal medium agar plates containing 0.1% potassium chromate. The sulfur requirements of these strains were tested on MSA plates lacking sodium sulfate but supplemented with 50 ,ug of the required sulfur source per ml.
Incorporation of isotope-labeled compounds into A47934. Isotope-labeled precursors at between 3 and 5 p.Ci/ml were added to 48-h production cultures of S. toyocaensis. Cultures were harvested at 72 h of age, and the antibiotic was extracted. HPLC analysis of the broth was carried out to determine incorporation of label into A47934 (see below).
Chromatography. HPLC of fermentation broths from cosynthesis studies was performed on a Nova (Waters Associates, Inc., Milford, Mass.) RCM C-18 column (8 by 100 mm). The solvent system consisted of 18% CH3CN in 0.2% aqueous ammonium acetate at a flow rate of 1.0 ml/min. A225 was used to monitor the presence of A47934 and A41030A (retention times of 23.4 and 12.5 min, respectively). For radioisotope-labeling experiments, the column was a Zorbax C8 (4.5 mm by 15 cm) and the solvent consisted of 0.2% aqueous triethylamine (pH 3.0) with a gradient of CH3CN from 5 to 80%. A Flow One Radioactive Flow Detector (Radiomatics) was used to monitor radioactivity directly off the HPLC column. The radioactive counts per minute obtained were converted to disintegrations per minute based on the standard curve generated for the solvent system used.
Thin-layer chromatography and bioautography of fermentation broths were performed using LK5 DF (Whatman, Inc., Clifton, N.J.) plates. Chromatograms were developed in a system consisting of CH3CN-CH3OH-H20 (8:1:1). Developed and dried chromatograms were placed on large agar plates seeded with B. subtilis. After 10 min, the chromatograms were removed and the agar plates were incubated at 37°C overnight. In this chromatographic system, A47934 and A41030A had Rf values of 0.7 and 0.3, respectively.
Sulfate transport studies. The uptake studies were carried out essentially as described by Kitano et al. (11) , except that the radioactive samples were counted in 10 ml of PCS solubilizer (Amersham Corp., Arlington Heights, Ill.). RESULTS
Incorporation of labeled substrates into A47934. To confirm that the precursors for A47934 were the same as other glycopeptides (6, 8, 9) , the labeled substrates shown in Table  1 were fed to antibiotic production cultures of S. toyocaensis. As expected, these select substrates were efficiently incorporated into A47934. These results are consistent with those obtained with other glycopeptide antibiotics of this class and suggest that tyrosine, PHPG, and DHPG via acetate are the amino acid precursors for this antibiotic. While the incorporation of acetate was low, it was reproducibly detectable. Extensive metabolism of the added acetate was indicated by the low levels of labeled material recovered in the fermentation broth (less than 6% of the material added (Table 2 ). This pattern was also seen in the frequency of blocked mutants isolated from the same experiment. Few blocked mutants were isolated when the MNNG level was sublethal, and the few mutants that were isolated were leaky for antibiotic synthesis.
Of the 36 blocked mutants isolated, only 9 produced antibiotic cosynthetically when paired with another mutant in typical secretor-convertor studies (Table 3) . HPLC analysis of the fermentation broth from the pairs cofermented in liquid production medium indicated that the antibiotic produced in all cases was A47934. However, the secretorconvertor pairs could be arranged in only two distinct groups (Table 3 Intermediates in the biosynthesis of A47934. The formation of A41030A (Fig. 1) any other antibiotic in the fermentation broth of these strains.
Sulfate-permease-negative mutants. To definitively establish the timing of sulfate addition, mutants blocked in sulfate permease were selected. Potassium chromate and sodium selenate were used to select for organisms resistant to these two sulfate analogs. S. toyocaensis was able to overcome its initial sensitivity to selenate and eventually overgrow MSA plates containing selenate (0.5 to 2.0%). This did not occur when chromate was used to select for these strains. Of the nine strains isolated, five grew on MSA plates supplemented with L-cysteine or L-methionine but did not grow on plates supplemented with sodium thiosulfate. The other four strains (frequency of 10'7 in nonmutated population) isolated were different. They grew on defined agar medium when supplemented with methionine, cysteine, or thiosulfate (but not sulfate). Transport studies (Fig. 2) demonstrated that the parental strain took up [35S]sulfate well and that this uptake was inhibited completely by 1.0 mM potassium chromate. One of the chromate-resistant strains was also studied and found to be incapable of transporting sulfate (Fig. 2) . Therefore, this strain, and most likely the others, was blocked in sulfate permease. None of the strains made antibiotic when grown on Bennett agar or in the complex liquid fermentation medium. This is consistent with other experiments which showed that the sulfate addition step must occur prior to the formation of any intermediates with antimicrobial activity.
Characterization of the sulfate permease in the parental strain indicated that unlabeled sulfate, selenate, chromate, thiosulfate and, to a lesser extent, cysteine, interfered with sulfate assimilation (Table 4) as determined by competition for labeled-sulfate uptake. L-Methionine had no effect on the uptake of labeled sulfate. These results are similar to those Each strain was grown separately for 2 days in vegetative medium and then for 2 days in fermentation medium at 30°C and 250 rpm. After this time, equal volumes of cultures were mixed and then grown for an additional 5 days. Antibiotic levels were determined by HPLC. obtained with the sulfate permease of Streptomyces griseus (11) . DISCUSSION The results of the incorporation studies with radioisotopelabeled precursors presented here are consistent with the literature precedents on the biosynthesis of the glycopeptide antibiotics (6, 8, 9) . Tyrosine and acetate are utilized to make up the peptide core of these antibiotics and also serve as precursors for A47934. A47934, however, lacks a sugar substituent but does possess a sulfate which, according to our incorporation data, is derived directly from sulfate in the medium. (13) , and enduracidin (10) . It is likely that the formation of this subunit in all three classes is similar. A logical sequence for the formation of PHPG would be tyrosine -, B-hydroxytyrosine --3-hydroxy-3(p-hydroxyphenyl)-pyruvate phydroxymandelate -* p-hydroxyphenylglyoxylate --PHPG. A better understanding of the formation of this unit might also shed some light on our blocked mutants of S. toyocaensis. Studies are under way to determine if the pathway outlined above is operative in the formation of PHPG units of glycopeptide antibiotics.
